DE69513332T2 - (Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren - Google Patents

(Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren

Info

Publication number
DE69513332T2
DE69513332T2 DE69513332T DE69513332T DE69513332T2 DE 69513332 T2 DE69513332 T2 DE 69513332T2 DE 69513332 T DE69513332 T DE 69513332T DE 69513332 T DE69513332 T DE 69513332T DE 69513332 T2 DE69513332 T2 DE 69513332T2
Authority
DE
Germany
Prior art keywords
alkyl
thia
cycloalkyl
alkoxy
indole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69513332T
Other languages
English (en)
Other versions
DE69513332D1 (de
Inventor
Paul Caubere
Brigitte Jamart-Gregoire
Catherine Caubere
Dominique Manechez
Pierre Renard
Gerard Adam
Catherine Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69513332D1 publication Critical patent/DE69513332D1/de
Application granted granted Critical
Publication of DE69513332T2 publication Critical patent/DE69513332T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69513332T 1994-06-28 1995-06-28 (Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren Expired - Fee Related DE69513332T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9407888A FR2721610B1 (fr) 1994-06-28 1994-06-28 Nouveaux dérivés (thia)cycloalkyl [b] indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
DE69513332D1 DE69513332D1 (de) 1999-12-23
DE69513332T2 true DE69513332T2 (de) 2000-07-27

Family

ID=9464699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69513332T Expired - Fee Related DE69513332T2 (de) 1994-06-28 1995-06-28 (Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren

Country Status (16)

Country Link
US (1) US5635516A (de)
EP (1) EP0690050B1 (de)
JP (1) JP3004566B2 (de)
CN (1) CN1054374C (de)
AT (1) ATE186722T1 (de)
AU (1) AU686800B2 (de)
CA (1) CA2152725A1 (de)
DE (1) DE69513332T2 (de)
DK (1) DK0690050T3 (de)
ES (1) ES2141904T3 (de)
FI (1) FI953193A (de)
FR (1) FR2721610B1 (de)
GR (1) GR3032172T3 (de)
NO (1) NO305022B1 (de)
NZ (1) NZ272447A (de)
ZA (1) ZA955355B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US20070225285A1 (en) * 2005-11-04 2007-09-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20070219206A1 (en) * 2005-11-04 2007-09-20 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US20070244128A1 (en) * 2005-11-04 2007-10-18 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7925075B2 (en) * 2007-05-07 2011-04-12 General Electric Company Inspection system and methods with autocompensation for edge break gauging orientation
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
KR20160129109A (ko) * 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-리폭시게나아제 활성화 단백질 억제제
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2018129205A1 (en) * 2017-01-04 2018-07-12 The Trustees Of Dartmouth College Methods of inhibiting pcsk9
CN108558905B (zh) * 2018-05-21 2021-03-12 华南农业大学 一种噻喃[4,3-b]吲哚类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2243574A1 (de) * 1972-09-05 1974-03-14 Boehringer Mannheim Gmbh Aryloxy-essigsaeure-derivate und verfahren zur herstellung derselben
GB1432649A (de) * 1973-09-07 1976-04-22 Ici Ltd
CA1326030C (en) * 1987-07-21 1994-01-11 John W. Gillard Cyclohept[b]indolealkanoic acids
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5221678A (en) * 1990-07-26 1993-06-22 Merck Frosst Canada, Inc. (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
AU3128693A (en) * 1991-11-18 1993-06-15 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
US5314900A (en) * 1992-11-19 1994-05-24 Merck Frosst Canada, Inc. Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU686800B2 (en) 1998-02-12
FR2721610A1 (fr) 1995-12-29
FR2721610B1 (fr) 1996-08-23
NO952579D0 (no) 1995-06-27
NO305022B1 (no) 1999-03-22
CA2152725A1 (fr) 1995-12-29
NO952579L (no) 1995-12-29
ES2141904T3 (es) 2000-04-01
GR3032172T3 (en) 2000-04-27
CN1054374C (zh) 2000-07-12
US5635516A (en) 1997-06-03
FI953193A0 (fi) 1995-06-28
DE69513332D1 (de) 1999-12-23
NZ272447A (en) 1996-02-27
EP0690050A1 (de) 1996-01-03
ZA955355B (en) 1996-02-12
ATE186722T1 (de) 1999-12-15
AU2327495A (en) 1996-01-11
EP0690050B1 (de) 1999-11-17
FI953193A (fi) 1995-12-29
JPH0812649A (ja) 1996-01-16
DK0690050T3 (da) 2000-04-17
CN1114957A (zh) 1996-01-17
JP3004566B2 (ja) 2000-01-31

Similar Documents

Publication Publication Date Title
DE69513332D1 (de) (Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren
NO943876D0 (no) Behandling av peri-menopausalt syndrom
DK0513379T3 (da) 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
DE68913930D1 (de) Serotonin- und Norepinephrin-Aufnahme-Inhibitoren.
UA27883C2 (uk) Засіб для інгібування небажаного відкладання фіброїдних тканин на стінці матки
AU640852B2 (en) N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
ATE109133T1 (de) Substituierte indol-, benzofuran- und benzothiophenderivate als 5- lipoxygenaseinhibitoren.
SE8006365L (sv) Cyklohexankarboxylsyraderivat
TW369528B (en) Alpha-substituted benzyl heterocyclic derivatives, a process for producing intermediates and containing the same as a fungicide or insecticide active ingredient
EA199800015A1 (ru) Способ ингибирования меланомы
ES461911A1 (es) Un procedimiento para la preparacion de nuevos compuestos antibioticos de cefalosporina.
KR870006049A (ko) 1-카바세팔로스포린 항생물질의 제조 방법
ATE159525T1 (de) Kondensierte naphthyridinderivate
ATE121394T1 (de) Konjugierte gamma-hydroxybutenolid-derivate und sie als aktiver wirkstoff enthaltende mittel gegen magengeschwüre.
EA199800677A1 (ru) Способ ингибирования опухоли толстой кишки
EP0513398A4 (en) Intermediate for synthesis of carbapenem and production of said intermediate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee